ライフサイエンスコーパス: drug-induced liver disease

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します

1 been proposed as another cause of suspected drug-induced liver disease.

2 sment remain an important aspect in defining drug-induced liver disease and proposed new upper limits

3 ulties inherent in establishing causality of drug-induced liver disease and the potential negative co

4 emains very involved in the process by which drug-induced liver disease can be detected early in drug

5 orms of liver injury, and several others had drug-induced liver disease confirmed by additional repor

6 A workshop on drug-induced liver disease cosponsored by the Food and D

7 drug withdrawals and new general reviews of drug-induced liver disease (DILD), including a review of

8 and first-time reports of various aspects of drug-induced liver disease for several classes of compou

9 se remains low, a large case-series of acute drug-induced liver disease from Spain and Sweden support

10 epidemiological and mechanistic features of drug-induced liver disease in 2005.

11 logical, and epidemiological descriptions of drug-induced liver disease in the calendar year 2004.

12 hold the key to treatment and prevention of drug-induced liver disease in the future and discusses t

13 nisms of injury to predict and avert serious drug-induced liver disease in the future from drugs unde

14 Although drug-induced liver disease is less common in children, s

15 Drug-induced liver disease remains an important cause of

16 Drug-induced liver disease remains an important topic of

17 While the frequency of drug-induced liver disease remains low, a large case-ser

18 any prescription drugs withdrawn because of drug-induced liver disease, the US Food and Drug Adminis

19 ies, more than half the instances of alleged drug-induced liver disease were found to have other caus

20 as the most commonly reported agents causing drug-induced liver disease, with acetaminophen continuin

WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。